SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-21-057771
Filing Date
2021-11-09
Accepted
2021-11-09 17:00:28
Documents
13
Period of Report
2021-11-03
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea150254-8k_aikidopharm.htm   iXBRL 8-K 24422
2 AMENDMENT TO THE AMENDED AND RESTATED BYLAWS OF THE AIKIDO PHARMA, INC. ea150254ex3-1_aikido.htm EX-3.1 5090
  Complete submission text file 0001213900-21-057771.txt   201971

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE aiki-20211103.xsd EX-101.SCH 3037
4 XBRL LABEL FILE aiki-20211103_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE aiki-20211103_pre.xml EX-101.PRE 22367
6 EXTRACTED XBRL INSTANCE DOCUMENT ea150254-8k_aikidopharm_htm.xml XML 3502
Mailing Address ONE ROCKEFELLER PLAZA, 11TH FLOOR NEW YORK NY 10020
Business Address ONE ROCKEFELLER PLAZA, 11TH FLOOR NEW YORK NY 10020 347-321-7646
AIkido Pharma Inc. (Filer) CIK: 0000012239 (see all company filings)

IRS No.: 520849320 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-05576 | Film No.: 211393073
SIC: 8731 Services-Commercial Physical & Biological Research